Hoitt Jason

Stoke Therapeutics, Inc. · Chief Patient Officer

Hoitt Jason is listed in public filings as officer: Chief Patient Officer. This Hoitt Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Stoke Therapeutics, Inc. (STOK). Investors use Hoitt Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Stoke Therapeutics, Inc.STOK$34k1k sharesSellMar 17, 2026$32.74--
Stoke Therapeutics, Inc.STOK$25k748 sharesSellMar 17, 2026$33.38--